Evaxion Brings Three-Year EVX-01 Melanoma Data to ESMO 2026
Evaxion will present three-year Phase 2 follow-up on its personalized neoantigen vaccine EVX-01 in advanced melanoma at ESMO 2026, with durability data pending.
Stories
Daniel Okafor
Stories
Daniel Okafor
Could Skin Reveal New Clues About Aging and Frailty?
New research attention is asking whether skin changes — visible, measurable and accessible — could serve as early markers of biol…
Reflectance Confocal Microscopy Caught Melanomas Earlier, Retrospective Study Finds
A retrospective Frontiers analysis reports earlier melanoma detection with in vivo reflectance confocal microscopy, adding cellul…
Male and Female Skin Play by Different Rules, Scientists Find
Scientists report male and female skin follow different biological rules, a finding with implications for trial design, treatment…
Second-Opinion Pathology Reviews Before Derm Surgery: A JAAD Look
A JAAD study published online October 17, 2026 measures how second-opinion pathology reviews before dermatologic surgery change c…
That Winter Itch May Not Be Dry Skin — It Could Be Eczema
A new report warns that persistent winter itching is not always dry skin — it may be eczema, a recurring inflammatory condition t…
In Utah, a $4.99 AI Acne App Can Now Issue Prescriptions
A $4.99 AI app in Utah now issues acne prescriptions as doctors review fewer cases, a shift with implications for access and over…
Indian Dermatology Online Journal Publishes Comprehensive Abrocitinib Review
A comprehensive abrocitinib review in the Indian Dermatology Online Journal is now indexed on Ovid, widening access for dermatolo…
Six Dermatologists Named ILDS 2027 Young Achiever Award Winners
The ILDS has named six recipients of its 2027 Young Dermatologist International Achievement Awards, spotlighting early-career der…
New Sunscreen Filter Reaches U.S. Shelves as Texas Reports Rising Melanoma
A new UV sunscreen filter has reached U.S. retail shelves just as melanoma rates climb in Texas, giving dermatologists a new coun…